Global and Japan Ertapenem Sodium Market Insights, Forecast to 2027

Ertapenem is a carbapenems antibiotic with strong antibacterial activity and broad antibacterial spectrum. CAS number is 153773-82-1.

Market Analysis and Insights: Global and Japan Ertapenem Sodium Market
This report focuses on global and Japan Ertapenem Sodium market.
In 2020, the global Ertapenem Sodium market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Ertapenem Sodium market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Ertapenem Sodium Scope and Market Size
Ertapenem Sodium market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Ertapenem Sodium market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Ertapenem Sodium market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Purity≥98%
Purity≥99%

Segment by Application
Ertapenem Sodium Injection
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Tecoland
Qilu Pharmaceutical
Beijing Lunarsun Pharmaceutical
Savior Lifetec Corporation
Zhejiang New Donghai Pharmaceutical
Iffect Chemphar
Sun Pharma

Frequently Asked Questions